Jeffrey A. Sosman

127.5k citations
347 papers · 28.5k indexed · 14 hit papers · h-index 73
Topics
Cancer Immunotherapy and Biomarkers (130 papers)Melanoma and MAPK Pathways (101 papers)CAR-T cell therapy research (88 papers)

In The Last Decade

Jeffrey A. Sosman

343 papers receiving 27.9k citations

Hit Papers

Temsirolimus, Interferon Alfa, or Both for Advanced Renal...19972026200620162007201020092010201350010001.5k2.0k2.5k

Peers

Jeffrey A. Sosman
Comparison fields: 5 of 149
  • Oncology 16.2k
  • Molecular Biology 15.5k
  • Pulmonary and Respiratory Medicine 8.3k
  • Immunology 6.9k
  • Cancer Research 5.0k
Replace Grant A. McArthur with:
Grant A. McArthur Australia
Keith T. Flaherty United States
Georgina V. Long Australia
Michael B. Atkins United States
Neal Rosen United States
Richard A. Scolyer Australia
David B. Solit United States
Martin Gore United Kingdom
Paolo A. Ascierto Italy
Richard Kefford Australia
Jeffrey A. Sosman relative to Grant A. McArthur Australia Grant A. McArthur's profile →
Citations per field
00.5×1.5×1.8×
Grant A. McArthur · 1×
Citations per year

Countries citing papers authored by Jeffrey A. Sosman

Since Specialization
Citations

This map shows the geographic impact of Jeffrey A. Sosman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Sosman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Sosman more than expected).

Fields of papers citing papers by Jeffrey A. Sosman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey A. Sosman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Sosman. The network helps show where Jeffrey A. Sosman may publish in the future.

Co-authorship network of co-authors of Jeffrey A. Sosman

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey A. Sosman. A scholar is included among the top collaborators of Jeffrey A. Sosman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey A. Sosman. Jeffrey A. Sosman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 19
2 58
3 35
4 28
5 109
6 144
7 16
8 132
9 20
10 23
11 82
12 65
13
Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapybreakdown →
715
14 124
15 356
16 75
17 148
18
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinomabreakdown →
1711
19 29
20 321

About Jeffrey A. Sosman

Jeffrey A. Sosman is a scholar working on Oncology, Immunology and Cancer Research, having authored 347 papers that have together received 28.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (130 papers), Melanoma and MAPK Pathways (101 papers) and CAR-T cell therapy research (88 papers). The work is most often cited by research in Oncology (16.2k citations), Cancer Research (5.0k citations) and Immunology (6.9k citations). Jeffrey A. Sosman has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Antoni Ribas, Douglas B. Johnson, Igor Puzanov, Grant A. McArthur, Michael B. Atkins, Keith T. Flaherty, Paul B. Chapman, Kevin B. Kim, K. B. Nolop and Vernon K. Sondak. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026